PHARMACEUTICAL DEALS

Pharmaceutical giants are making headlines again, but this time, it's not about new drugs. Merck and eight other big players have joined Pfizer, Lilly, and Novo in signing Most Favored Nation (MFN) deals. These agreements aim to make medicines more affordable by tying drug prices to the lowest price

The Trump administration struck a deal with Novo Nordisk and Eli Lilly to lower the cost of GLP-1 drugs. These drugs help with weight loss, diabetes, and other health issues. Starting soon, people will pay about $350 a month for these injectable drugs. This price will drop to $250 over the next two